Skip to main content
Click here to get access to our Free Course on Momentum Investing Strategy

NSE · CAMLINFINE

CAMLINFINE

CommoditiesChemicals & Petrochemicals₹2350 cr market cap
₹71.14 ▼ -1.4% today As of 19 Nov 2026
52-week low ₹72.1552-week high ₹177.37

-59.3% from the 52-week high · +0.0% above the low

Camlin Fine Sciences Ltd. engages in the research, development, manufacture, and marketing of fine chemicals which are used as antioxidants, industrial chemicals, and aroma products. The company is headquartered in Mumbai, Maharashtra and currently employs 478 full-time employees. The company went IPO on 2015-01-20. The firm is a provider of antioxidants and shelf-life solutions, aroma ingredients, health and wellness, and performance chemicals. Its products include BHA, TBHQ and GUAIACOL BULK. The firm offers its products across various industries, including food and beverages, animal nutrition, pet food, aquaculture, bio-fuels, pharmaceuticals, dyes and pigments, petrochemicals and polymers. The company manufactures Methyl Vanillin which is sold under the Company’s brand name VanesseTM and Ethyl Vanillin, that is used in a range of applications, such as chocolates, ice creams, bakery products, incense sticks, perfumes, soaps, personal care and cosmetic products. Its performance chemicals business is involved in providing specialty chemicals, including Guaiacol, Veratrole, TBC, MEHQ, CME, HQEE, Hydroquinone and Catechol.

The short version. CAMLINFINE reported revenue of ₹491 crore for Sep 2026, up 6.7% from a year earlier. Net profit was ₹-28 crore. Return on equity was 2.6% in Mar 2026. Promoter holding was 48.03% in Sep 2026, up 0.01 points over 8 quarters.

1 · The price

How has the stock traded?

CAMLINFINE trades 59.3% below its 52-week high and 0.0% above its 52-week low.

Change over period: —

1M-21.2%
3M-32.0%
6M-40.5%
1Y-55.3%

2 · The business

Is it growing?

Sales, year on year+6.7%

Sep 2026 revenue of ₹491 cr.

Net margin-5.7%

2.6 pts lower than a year earlier.

3-year growth-19.1% profit

Revenue compounded at 1.3% over the same 3 years.

Reported results · ₹ crore

Revenue and profit

Show the numbers

Quarterly

Sep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue491520425457460424437433
Net profit-28-3288-36-14-10-1-4
Net margin %-5.7-6.120.8-7.9-3.1-2.4-0.2-1.0
EPS (₹)-1.45-1.654.59-1.89-0.77-0.53-0.04-0.22

Annual

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Revenue1723166716131682141211871049892
Net profit28-139-93526151304
Net margin %1.6-8.3-5.83.14.34.32.90.4
EPS (₹)1.44-7.4-4.942.963.453.562.230.29

3 · The quality

How well does it turn capital into profit?

Return on equity was 2.6% in Mar 2026; debt to equity is 0.64.

Profitability · 4 years

Returns and margins

Mar 2026Mar 2025Mar 2024Mar 2023
Return on equity %2.6-15.4-10.76.4
Return on capital %2.912.7-3.211.0
EBITDA margin %6.312.72.411.9
Net margin %1.6-8.3-5.73.1

Compound growth

Revenue vs profit

3 years5 years
Revenue CAGR1.3%8.0%
Profit CAGR-19.1%-11.5%
Debt to equity0.64
Interest cover0.5x
Current ratio1.27

4 · The owners

Who holds it, and are they adding?

Promoter holding48.03%

Up 0.01 pts over 8 quarters.

Foreign institutions0.95%

Up 0.19 pts over 8 quarters.

Domestic institutions5.32%

Up 1.93 pts over 8 quarters.

Mutual fund schemes3

+0 versus the previous month.

Shareholding pattern (%)

Quarter by quarter

Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Change
Promoter48.0249.149.149.0848.0348.0348.0348.03+0.01
FII0.761.472.882.122.120.940.910.95+0.19
DII3.393.834.145.487.777.75.425.32+1.93
Public47.8345.6143.8743.3342.0843.3245.6445.7-2.13

Mutual fund holdings · Oct 2026

3 schemes hold this stock

3 the month before.

  • ICICI Prudential Commodities Fund1.32% of NAV
  • ICICI Prudential Multi Cap Fund0.16% of NAV
  • ICICI Prudential Mid Cap Fund0.01% of NAV

See what mutual funds are buying

5 · The model view

What does our factor model say?

Factor scores, model flags and screen results for CAMLINFINE are part of the Wright portfolio review.

Run your free portfolio review

Watchouts

What to review

Model flags are shown inside the portfolio review, alongside your other holdings.

Model ratingLocked
Factor betaLocked
VolatilityLocked

Quick answers

Common questions about CAMLINFINE

What is the CAMLINFINE share price?

CAMLINFINE (CAMLINFINE) last closed at ₹71.14, down 1.4% on the day. Its 52-week range is ₹72.15 to ₹177.37.

What is the market cap of CAMLINFINE?

CAMLINFINE has a market capitalisation of about ₹2,350 crore.

How are CAMLINFINE's latest results?

CAMLINFINE reported revenue of ₹491 crore for Sep 2026, up 6.7% from a year earlier. Net profit was ₹-28 crore. Return on equity was 2.6% in Mar 2026. Promoter holding was 48.03% in Sep 2026, up 0.01 points over 8 quarters.

Who owns CAMLINFINE?

As of Sep 2026, shareholding was: Promoter 48.03%, FII 0.95%, DII 5.32%, Public 45.7%.

How many mutual funds hold CAMLINFINE?

3 mutual fund schemes held CAMLINFINE in October 2026. That compares with 3 the month before.

Corporate actions

Recent dividends, bonuses and splits

  • 08 Jan 2025 · Rights issue 5:41
  • 28 Jul 2016 · Dividend - Rs. 0.45
  • 27 Jul 2015 · Dividend - Rs. 0.45
  • 04 Sep 2014 · Stock Split From Rs.2/- to Rs.1/-
  • 24 Jul 2014 · Dividend - Rs. 0.7

Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.

Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.